Curaleaf Holdings (CURLF) Other Accumulated Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Other Accumulated Expenses of $5.6 million for Q4 2025, up 761.35% year-over-year from $652000.0 in Q4 2024, and up 761.35% quarter-over-quarter from $652000.0 in Q4 2024.
Curaleaf Holdings (CURLF) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 761.35% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at $5.6 million (up 761.35% YoY), while the FY2025 annual figure was $5.6 million, up 761.35% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $5.6 million, up from $652000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $12.2 billion in Q1 2022, with the low at $359000.0 in Q3 2023.
- The 5-year median for Other Accumulated Expenses is $4.5 million (2024), against an average of $881.6 million.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 840959.15% in 2022, then plunged 98.81% in 2023.
- Curaleaf Holdings' Other Accumulated Expenses stood at $12.2 million in 2021, then soared by 147.93% to $30.2 million in 2022, then tumbled by 95.84% to $1.3 million in 2023, then sank by 48.09% to $652000.0 in 2024, then soared by 761.35% to $5.6 million in 2025.
- Business Quant data shows CURLF's Other Accumulated Expenses at $5.6 million in Q4 2025, $652000.0 in Q4 2024, and $3.4 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Dec 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 652,000.00 |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 359,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Sep 30, 2022 | 30.17 Mn |
| Jun 30, 2022 | 28.86 Mn |
| Mar 31, 2022 | 12.23 Bn |
| Dec 31, 2021 | 12.17 Mn |
| Sep 30, 2021 | 12.57 Mn |
| Jun 30, 2021 | 13.08 Mn |
| Mar 31, 2021 | 1.45 Mn |
| Dec 31, 2020 | 6.57 Mn |
| Sep 30, 2020 | 6.81 Mn |
| Dec 31, 2019 | 31.55 Mn |